F. Caux
Inserm(FR)Nord University(NO)Université Sorbonne Paris Nord(FR)Assistance Publique – Hôpitaux de Paris(FR)Hôpital Avicenne(FR)Physiopathologie, cibles et thérapies de la polyarthrite rhumatoïde
Publications by Year
Research Areas
Autoimmune Bullous Skin Diseases, Coagulation, Bradykinin, Polyphosphates, and Angioedema, Urticaria and Related Conditions, PI3K/AKT/mTOR signaling in cancer, Platelet Disorders and Treatments
Most-Cited Works
- → First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial(2017)587 cited
- → Mutations in CGI-58, the Gene Encoding a New Protein of the Esterase/Lipase/Thioesterase Subfamily, in Chanarin-Dorfman Syndrome(2001)461 cited
- → A Single Cycle of Rituximab for the Treatment of Severe Pemphigus(2007)461 cited
- → High cumulative risks of cancer in patients with PTEN hamartoma tumour syndrome(2013)364 cited
- → Diagnosis and management of pemphigus: Recommendations of an international panel of experts(2018)360 cited
- → Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)(2020)323 cited